Cassling Diagnostic Imaging changes name as scope broadens

Cassling Diagnostic Imaging has changed its name to Cassling to reflect its growing scope of products and services and all future business will be undertaken with the new name.

Over the past two decades, Cassling, which has been a full-line sales and service dealer for Siemens Medical Solutions since 2001, has provided diagnostic imaging equipment to healthcare organizations in Iowa, Kansas, Nebraska, South Dakota and select counties in Illinois and Missouri. The portfolio has expanded to include clinical networking, therapy and molecular imaging products as well as professional services, Cassling said.

While the company name has changed, Cassling's organizational structure and relationship with Siemens remains the same, the company noted.

"We recognize that healthcare is a constantly changing industry and our customers need more than diagnostic imaging equipment to respond to those changes. Our goal is to help our customers strengthen healthcare in the communities they serve by providing a more comprehensive set of solutions," said President and CEO Mike Cassling.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.